IGI Laboratories Company Profile (NYSE:IG)

About IGI Laboratories (NYSE:IG)

IGI Laboratories logoIGI Laboratories, Inc. is a specialty generic pharmaceutical company. Under its IGI label, the Company sells generic topical pharmaceutical products that are bioequivalent to their brand name counterparts. The Company provides development, formulation and manufacturing services to the pharmaceutical, over-the-counter (OTC) and cosmetic industries. The Company has two platforms for growth: developing, manufacturing and marketing a portfolio of generic pharmaceutical products under its own label in topical, injectable, complex and ophthalmic dosage forms, and managing its current contract manufacturing and formulation services business. The Company also develops, manufactures, fills and packages topical semi-solid and liquid products for branded and generic pharmaceutical customers, as well as the OTC and cosmetic markets. These products are used in a range of applications from cosmetics to the prescription treatment of conditions like dermatitis, psoriasis and eczema.

Industry, Sector and Symbol:
  • Sector: N/A
  • Industry: N/A
  • Sub-Industry: N/A
  • Symbol: NYSE:IG
  • CUSIP: N/A
  • Web: N/A
Average Prices:
  • 50 Day Moving Avg: $7.71
  • 200 Day Moving Avg: $7.24
  • 52 Week Range: $4.75 - $12.05
P/E:
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: 64.00
  • P/E Growth: 0.00
Misc:
  • Average Volume: 583,158 shs.
 

Frequently Asked Questions for IGI Laboratories (NYSE:IG)

What is IGI Laboratories' stock symbol?

IGI Laboratories trades on the New York Stock Exchange (NYSE) under the ticker symbol "IG."

How were IGI Laboratories' earnings last quarter?

IGI Laboratories, Inc. (NYSE:IG) released its earnings results on Thursday, October, 22nd. The company reported ($0.02) earnings per share for the quarter, topping analysts' consensus estimates of ($0.05) by $0.03. The firm had revenue of $11.60 million for the quarter, compared to the consensus estimate of $9.36 million. The business's quarterly revenue was up 73.1% compared to the same quarter last year. View IGI Laboratories' Earnings History.

Who are some of IGI Laboratories' key competitors?

How do I buy IGI Laboratories stock?

Shares of IGI Laboratories can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

How much does a share of IGI Laboratories stock cost?

One share of IGI Laboratories stock can currently be purchased for approximately $7.68.

Analyst Ratings

Consensus Ratings for IGI Laboratories (NYSE:IG) (?)
Ratings Breakdown: No ratings tracked in the last 12 months.
Consensus Rating:N/A (Score: NaN)
Consensus Price Target: N/A

Analysts' Ratings History for IGI Laboratories (NYSE:IG)
Show:
DateFirmActionRatingPrice TargetImpact on Share PriceDetails
10/23/2015Roth CapitalReiterated RatingBuyN/AView Rating Details
9/9/2015JMP SecuritiesInitiated CoverageMarket PerformN/AView Rating Details
7/20/2015Oppenheimer Holdings Inc.Reiterated RatingMarket PerformN/AView Rating Details
(Data available from 5/27/2015 forward)

Earnings

Earnings History for IGI Laboratories (NYSE:IG)
Earnings by Quarter for IGI Laboratories (NYSE:IG)
Earnings History by Quarter for IGI Laboratories (NYSE:IG)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
10/22/2015Q315($0.05)($0.02)$9.36 million$11.60 millionViewListenView Earnings Details
7/23/2015Q2($0.08)($0.04)$7.63 million$8.90 millionViewListenView Earnings Details
3/2/2015Q414$0.06$0.09$11.88 million$13.70 millionViewN/AView Earnings Details
7/24/2014($0.01)ViewN/AView Earnings Details
2/27/2014Q4$0.01($0.01)ViewListenView Earnings Details
11/13/2012Q312($0.04)$2.11 million$1.98 millionViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for IGI Laboratories (NYSE:IG)
Current Year EPS Consensus Estimate: $-0.08 EPS
Next Year EPS Consensus Estimate: $0.12 EPS

Dividends

Dividend History for IGI Laboratories (NYSE:IG)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading and Institutional Ownership History for IGI Laboratories (NYSE:IG)
Insider Trades by Quarter for IGI Laboratories (NYSE:IG)
Insider Trades by Quarter for IGI Laboratories (NYSE:IG)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
9/1/2015Jason Grenfell-GardnerCEOSell84,048$7.94$667,341.12View SEC Filing  
4/30/2015James C GaleDirectorBuy30,000$5.04$151,200.00View SEC Filing  
3/5/2015Sciences Opportunities Fu LifeMajor ShareholderSell2,000,000$9.95$19,900,000.00View SEC Filing  
9/2/2014Sciences Opportunities Fu LifeMajor ShareholderSell2,000,000$6.45$12,900,000.00View SEC Filing  
8/27/2014Sciences Opportunities Fu LifeMajor ShareholderSell3,000,000$6.20$18,600,000.00View SEC Filing  
8/22/2014James C GaleDirectorBuy5,000$5.90$29,500.00View SEC Filing  
8/4/2014Jason Grenfell-GardnerCEOSell66,828$5.85$390,943.80View SEC Filing  
6/9/2014Joyce EronyDirectorSell17,500$5.48$95,900.00View SEC Filing  
8/6/2013Michael B HemricDirectorBuy50,000$1.48$74,000.00View SEC Filing  
5/24/2013Jason Grenfell-GardnerCEOBuy3,500$1.55$5,425.00View SEC Filing  
3/13/2013James C GaleDirectorBuy10,000$1.33$13,300.00View SEC Filing  
3/12/2013Michael B HemricDirectorBuy20,637$1.19$24,558.03View SEC Filing  
8/14/2012Jason Grenfell-GardnerCEOBuy10,000$1.15$11,500.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Headline Trends for IGI Laboratories (NYSE:IG)
Latest Headlines for IGI Laboratories (NYSE:IG)
Source:
DateHeadline
americanbankingnews.com logoIGI Laboratories (IG) Receives Daily News Impact Rating of -0.01
www.americanbankingnews.com - April 18 at 6:48 PM
finance.yahoo.com logoIGI Laboratories, Inc. breached its 50 day moving average in a Bullish Manner : September 24, 2015
finance.yahoo.com - April 7 at 10:25 AM
finance.yahoo.com logoETF’s with exposure to IGI Laboratories, Inc. : September 24, 2015
finance.yahoo.com - April 7 at 10:25 AM
finance.yahoo.com logoWhy This Small-Cap Healthcare Stock Can Continue to Win
finance.yahoo.com - April 7 at 10:25 AM
finance.yahoo.com logoForget Big Pharma: These Little Stocks Offer Far Richer Investing Opportunities
finance.yahoo.com - April 7 at 10:25 AM
finance.yahoo.com logoExciting News Positions IGI Laboratories Inc for Even More Fast Growth
finance.yahoo.com - April 7 at 10:25 AM
finance.yahoo.com logoIGI Laboratories, Inc. breached its 50 day moving average in a Bearish Manner : October 21, 2015
finance.yahoo.com - April 7 at 10:25 AM
finance.yahoo.com logoWhy IGI Laboratories Soared Today
finance.yahoo.com - April 7 at 10:25 AM
finance.yahoo.com logoIGI Laboratories, Inc. Earnings Q3, 2015
finance.yahoo.com - April 7 at 10:25 AM
finance.yahoo.com logoShould You Buy Addus Homecare Corporation (ADUS)?
finance.yahoo.com - April 7 at 10:25 AM
bizjournals.com logo4 reasons why a Bucks County pharma firm attracted a $19.5M investment - Philadelphia Business Journal
www.bizjournals.com - December 8 at 11:29 PM
prnewswire.com logoTeligent, Inc. Appoints Dr. Carole Ben-Maimon To Board Of Directors - PR Newswire (press release)
www.prnewswire.com - March 31 at 1:54 PM
prnewswire.com logoTeligent, Inc. Announces Launch Of Cefotan® (Cefotetan For Injection) - PR Newswire (press release)
www.prnewswire.com - March 21 at 2:10 PM
biz.yahoo.com logoTELIGENT, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and Exhibits
biz.yahoo.com - December 4 at 6:05 AM
finance.yahoo.com logoTELIGENT, INC. Financials
finance.yahoo.com - October 29 at 1:04 PM

Social

Chart

IGI Laboratories (IG) Chart for Saturday, May, 27, 2017

This page was last updated on 5/27/2017 by MarketBeat.com Staff